Elevated BDNF protein level in cortex but not in hippocampus of MDMA-treated Dark Agouti rats: A potential link to the long-term recovery of serotonergic axons

Neuroscience Letters

Volumn 478, Issue 2, 2010, Pages 56-60

  Ádori, Csaba ^a   Andó, Rómeó D ^b   Ferrington, Linda ^c   Szekeres, Mária ^a   Vas, Szilvia ^a   Kelly, Paul A T ^c   Hunyady, László ^a   Bagdy, György ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

3,4 Methylenedioxymethamphetamine (ecstasy); Brain derived neurotrophic factor (BDNF); ELISA; Paroxetine binding; Serotonin; Tryptophan hydroxylase (TpH)

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; BRAIN DERIVED NEUROTROPHIC FACTOR; PAROXETINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CELL DENSITY; CONTROLLED STUDY; DARK AGOUTI RAT; HIPPOCAMPUS; MALE; NONHUMAN; PARIETAL LOBE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SEROTONINERGIC NERVE CELL;

ANIMALS; AXONS; BRAIN-DERIVED NEUROTROPHIC FACTOR; HIPPOCAMPUS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PARIETAL LOBE; PAROXETINE; PROTEIN BINDING; RADIOLIGAND ASSAY; RATS; SEROTONIN; STREET DRUGS; TIME FACTORS; TRYPTOPHAN HYDROXYLASE;

EID: 77953609957     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.04.061     Document Type: Article

References (31)

1. Adori C., Ando R.D., Kovacs G.G., Bagdy G. Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: temporal, spatial, and cellular patterns. J. Comp. Neurol. 2006, 497:251-269.
2. Ando R.D, Benko A., Ferrington L., Kirilly E., Kelly P.A., Bagdy G. Partial lesion of the serotonergic system by a single dose of MDMA results in behavioural disinhibition and enhances acute MDMA-induced social behaviour on the social interaction test. Neuropharmacology 2006, 50:884-896.
3. Angelucci F., Gruber S.H., El Khoury A., Tonali P.A., Mathe A.A. Chronic amphetamine treatment reduces NGF and BDNF in the rat brain. Eur. Neuropsychopharmacol. 2007, 17:756-762.
4. Balogh B., Molnar E., Jakus R., Quate L., Olverman H.J., Kelly P.A., Kantor S., Bagdy G. Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA. Psychopharmacology (Berl.) 2004, 173:296-309.
5. Banerjee P.S., Aston J., Khundakar A.A., Zetterstrom T.S. Differential regulation of psychostimulant-induced gene expression of brain derived neurotrophic factor and the immediate-early gene Arc in the juvenile and adult brain. Eur. J. Neurosci. 2009, 29:465-476.
6. Capela J.P., Carmo H., Remiao F., Bastos M.L., Meisel A., Carvalho F. Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol. Neurobiol. 2009, 39:210-271.
7. De Souza E.B., Kuyatt B.L. Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain. Synapse 1987, 1:488-496.
8. Fischer C., Hatzidimitriou G., Wlos J., Katz J., Ricaurte G. Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, " ecstasy" ). J. Neurosci. 1995, 15:5476-5485.
9. Frechilla D., Insausti R., Ruiz-Golvano P., Garcia-Osta A., Rubio M.P., Almendral J.M., Del Rio J. Implanted BDNF-producing fibroblasts prevent neurotoxin-induced serotonergic denervation in the rat striatum. Brain Res. Mol. Brain Res. 2000, 76:306-314.
10. Green A.R., Mechan A.O., Elliott J.M., O'Shea E., Colado M.I. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, " ecstasy" ). Pharmacol. Rev. 2003, 55:463-508.
11. Kindlundh-Hogberg A.M., Zhang X., Svenningsson P. S100B overexpressing mutant mice exhibit prolonged behavioural and biochemical responses towards repeated intermittent binge treatments with MDMA. Int. J. Neuropsychopharmacol. 2009, 12:201-215.
12. Kirilly E., Molnar E., Balogh B., Kantor S., Hansson S.R., Palkovits M., Bagdy G. Decrease in REM latency and changes in sleep quality parallel serotonergic damage and recovery after MDMA: a longitudinal study over 180 days. Int. J. Neuropsychopharmacol. 2008, 11:795-809.
13. Koprich J.B., Campbell N.G., Lipton J.W. Neonatal 3,4-methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat. Brain Res. Dev. Brain Res. 2003, 147:177-182.
14. Lew R., Sabol K.E., Chou C., Vosmer G.L., Richards J., Seiden L.S. Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II. Radioligand binding and autoradiography studies. J. Pharmacol. Exp. Ther. 1996, 276:855-865.
15. Lykissas M.G., Batistatou A.K., Charalabopoulos K.A., Beris A.E. The role of neurotrophins in axonal growth, guidance, and regeneration. Curr. Neurovasc. Res. 2007, 4:143-151.
16. Mamounas L.A, Altar C.A., Blue M.E., Kaplan D.R., Tessarollo L., Lyons W.E. BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J. Neurosci. 2000, 20:771-782.
17. Martinez-Turrillas R., Moyano S., Del Rio J., Frechilla D. Differential effects of 3,4-methylenedioxymethamphetamine (MDMA, " ecstasy" ) on BDNF mRNA expression in rat frontal cortex and hippocampus. Neurosci. Lett. 2006, 402:126-130.
18. Mattson M.P., Maudsley S., Martin B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 2004, 27:589-594.
19. Meredith G.E., Callen S., Scheuer D.A. Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration. Brain Res. 2002, 949:218-227.
20. Meyer M, Matsuoka I., Wetmore C., Olson L., Thoenen H. Enhanced synthesis of brain-derived neurotrophic factor in the lesioned peripheral nerve: different mechanisms are responsible for the regulation of BDNF and NGF mRNA. J. Cell Biol. 1992, 119:45-54.
21. Molliver M.E., Berger U.V., Mamounas L.A., Molliver D.C., O'Hearn E., Wilson M.A. Neurotoxicity of MDMA and related compounds: anatomic studies. Ann. N. Y. Acad. Sci. 1990, 600:649-661. (discussion 661-644).
22. Mordenti J., Chappell W. The use of interspecies scaling in toxicokinetics. Toxikokinetics and New Drug Development 1989, Pergamon Press, New York, pp. 42-96. A. Yacobi, V.K. Batra (Eds.).
23. O'Shea E., Granados R., Esteban B., Colado M.I., Green A.R. The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy'). Neuropharmacology 1998, 37:919-926.
24. Paxinos G. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press Inc. second ed.
25. Piper B.J., Farelli J.D., Meyer J.S. Dissociation between serotonin neurotoxicity and brain-derived neurotrophic factor induction following neonatal MDMA exposure in rats. Dev. Neurosci. 2009, 31:90-94.
26. Sabol K.E., Lew R., Richards J.B., Vosmer G.L., Seiden L.S. Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I. Synaptosomal uptake and tissue concentrations. J. Pharmacol. Exp. Ther. 1996, 276:846-854.
27. Scanzello C.R., Hatzidimitriou G., Martello A.L., Katz J.L., Ricaurte G.A. Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats. J. Pharmacol. Exp. Ther. 1993, 264:1484-1491.
28. Sharkey J., McBean D.E., Kelly P.A. Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine (" ecstasy" ). Psychopharmacology (Berl.) 1991, 105:113-118.
29. Vaidya V.A., Marek G.J., Aghajanian G.K., Duman R.S. 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J. Neurosci. 1997, 17:2785-2795.
30. Weissmann D., Belin M.F., Aguera M., Meunier C., Maitre M., Cash C.D., Ehret M., Mandel P., Pujol J.F. Immunohistochemistry of tryptophan hydroxylase in the rat brain. Neuroscience 1987, 23:291-304.
31. Zetterstrom T.S., Pei Q., Madhav T.R., Coppell A.L., Lewis L., Grahame-Smith D.G. Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain. Neuropharmacology 1999, 38:1063-1073.